PATENT CLAIM ANALYSIS

Application Number: 15894377
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
A novel dosage form for delivering an opioid antagonist such as naloxone is disclosed. The dosage form comprises an oral dissolvable film containing an amount of the opioid antagonist effective to reduce or counteract the effect of an opioid overdose in an individual. Methods of administering the dosage form to an individual experiencing an opioid overdose are also disclosed.

Claim (Index 18):
The method of  claim 14 , comprising administering to the individual one or more subsequent doses of the dosage form.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.63158
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14882857', '15117114', '14942344', '14950707', '15428705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7523216972796635
- 35 USC 102 Novelty (BERT): 0.5161762012592763
- Combined Prediction Score: 0.7287071476776248
- Mean Citation Score: 256.078062
- Max Citation Score: 265.05618
- Similarity Product: 152.7036816908491

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test